LL-37
Cathelicidin antimicrobial peptide investigated for chronic infection and biofilm clearance.
Scientific Overview
Sole human cathelicidin. Investigated for SIBO, chronic Lyme, and biofilm-forming infections; cytotoxic at high concentrations.
Key Research Benefits
- ✓Broad antimicrobial
- ✓Biofilm disruption
- ✓Immune modulation
Potential Side Effects
Research Protocols
Common DosagesAntimicrobial Cycle
“Cycle 2–4 weeks”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.08 mL on a U-100 syringe
Explore LL-37
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Other
- Common Dosage
- 100–300 mcg
- Daily (5 on / 2 off)
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.